About the Department of Hematology, Internal Oncology, Stem Cell Transplantation and Hemostaseology at University Hospital Mainz
The Department of Hematology, Internal Oncology, Stem Cell Transplantation and Hemostaseology at the University Hospital Mainz offers the full range of services in the field of diagnostics and treatment of systemic diseases with high malignancy degree, including diseases of blood, bone marrow and lymphatic system. Treatment involves the use of the very latest therapeutic techniques, including autologous and allogeneic stem cell transplantation. The Chief Physician of the department is Prof. Dr. med. Matthias Theobald.
The department offers the following range of diagnostics and treatment of hematologic diseases:
- Anemia and hematopoietic disorders with erythrocyte deficiency (erythropenia)
- Leukocyte deficiency (leukopenia) and changes in leukocyte formula
- Platelet deficiency (immune and thrombotic thrombocytopenic purpura)
- Myeloproliferative diseases
- Myelodysplastic syndrome
- Acute and chronic leukemia
- Lymphoproliferative disorders (Hodgkin's disease, non-Hodgkin's lymphoma)
- Multiple myeloma (plasmacytoma)
- And other blood diseases
An experienced team of the department ensures competent performance of all modern diagnostic and therapeutic procedures at the highest scientific level. The offered range of therapeutic services includes treatment methods, such as transfusion therapy, growth factor therapy, chemo-, immuno- and molecular targeted therapy, as well as prevention and treatment of infections. At the same time, autologous and allogeneic stem cell transplantation is often an important part of the hematologic diseases treatment.
Another major focus of the department is internal oncology, which deals with the diagnostics, treatment and follow-up examination of patients with malignant diseases of all organ systems.
The department offers treatment of the following oncological diseases:
- Lung tumors
- Connective tissue and bone tumors (sarcomas)
- Urinary tract tumors (kidney, bladder, ureter and urethra)
- Head and neck tumors
- Complex oncological diseases
- Counseling on breast carcinoma, CNS tumors and endocrine tumors
- As well as oncological diseases of other organs
In addition, in the field of hemostaseology, the department offers diagnostics and treatment of all congenital and acquired blood clotting disorders. These include both hemophilia A and B, von Willebrand disease, rare deficiencies of blood clotting factors and platelet function disorders (thrombocytopathy). There are all modern diagnostic and therapeutic options in the arsenal of the department. The substitution therapy is provided with the help of blood components and plasma in the day hospital. The treatment of complex blood clotting disorders is provided at the Comprehensive Care Center (CCC).
In general, the main clinical priorities of the department include the following medical fields:
- Hematology (diagnostics and treatment of all diseases of blood, bone marrow and lymphatic system)
- Stem cell transplantation (in various hematological diseases)
- Internal oncology (diagnostics and treatment of malignant diseases of all organ systems)
- Hemostaseology (diagnostics and treatment of all congenital and acquired blood clotting disorders)
- Interdisciplinary palliative care
Curriculum vitae
Education, Training and Professional Experience
- 1981 - 1987 Study of Chemistry, Human Biology and Medicine at the Universities of Giessen, Marburg, Mainz and Ulm.
- 1987 Medical examination and admission to medical practice.
- 1989 Doctoral thesis defence and the title of the Candidate of Medical Sciences (magna cum laude), Department of Internal Medicine, University of Ulm.
- 1987 - 1992 Research Fellow/Assistant Physician, Department of Internal Medicine III, University Hospital Ulm.
- 1992 - 1995 Scholarship and Research Fellow, Department of Immunology, Scripps Research Institute, La Jolla, California.
- 1995 - 1996 Research Fellow/Assistant Physician, Department of Hematology, Internal Oncology, Stem Cell Transplantation and Hemostaseology at the University Hospital Mainz.
- 1996 Certified Therapist.
- 1997 Invitation to the position of Associate Professor, Medical College of Wisconsin (MCW), Bone Marrow Transplantation Program and part-time Corresponding Member of the Blood Research Institute Milwaukee, Wisconsin.
- 1996 - 2006 Senior Physician, Department of Hematology, Internal Oncology, Stem Cell Transplantation and Hemostaseology at the University Hospital Mainz.
- 1998 Doctoral thesis defence, Venia Legendi, Internal Medicine, Faculty of Medicine, Johannes Gutenberg University Mainz.
- 2000 Specialization: Hematology and Internal Oncology.
- 2003 - 2006 Invitation to the post of (C3) University Professor, Professor of the Jose Carreras Foundation, Department of Internal Medicine, Faculty of Medicine, Johannes Gutenberg University Mainz.
- 2004 - 2006 Medical Director, Department of Hematology, Internal Oncology, Stem Cell Transplantation and Hemostaseology at the University Hospital Mainz.
- 2006 - 2009 Invitation to the position of Full Professor of Hematology, Head of the Department of Hematology, Van Creveld Hospital, University Medical Center of Utrecht, Netherlands, as well as the Department of Immunology.
- Since 2008 Board Committee Member of the Research Center for Immunology (FZI), Johannes Gutenberg University Mainz.
- Since 2009 Invitation to the position of (W3) University Professor in Hematology/Oncology, Head of the Department of Internal Medicine at the University Hospital Mainz.
- 2010 - 2013 Board Member of the Center for Thrombosis and Hemostasis (CTH) at the University Hospital Mainz.
- 2010 - 2013 Speaker of the Clinical Research Group KFO 183 "Optimized Allogeneic Lymphocyte Therapy" of the German Research Foundation (DFG) at the University Hospital Mainz.
- 2011 - 2016 Board Speaker of the Mainz University Cancer Center (UCT) at the University Hospital Mainz.
- Since 2013 Representative of the German Society of Hematology and Oncology (DGHO) in the Commission "Clinical Trials in Oncology" of the German Cancer Society (DKG).
- Since 2013 Speaker of the Mainz medical staff in the German Consortium for Translational Cancer Research (DKTK), Frankfurt/Mainz.
- Since 2014 Representative of the German Society of Hematology and Oncology (DGHO) at the German Society of Internal Medicine (DGIM).
- Since 2016 Representative of the German Society of Hematology and Oncology (DGHO) at the Scientific Council of the Paul Ehrlich Institut in "Tissue Engineering Technology".
- Since 2016 Head of the University Cancer Center (UCT) at the University Hospital Mainz.
Membership in the Scientific Communities (selectively)
- German Society of Hematology and Oncology.
- German Society for Internal Medicine.
- German Society for Bone Marrow and Stem Cell Transplantation.
- European Group for Blood and Marrow Transplantation.
- European Hematology Association.
- American Society of Hematology.
Photo of the doctor: (c) Universitätsmedizin der Johannes Gutenberg-Universität Mainz